Abstract:Background: Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen associated with serious hospital acquired infections. It is resistant to multiple antibiotics. The therapy for infections due to this bacterium is a combination of aminoglycosides with carbapenem antibiotics. There are recent reports of the prevalence of ami-noglycoside resistance among A. baumannii. The aim of the present study was to determine the prevalence of phosphotransferases APH (3')-Via (aphA6), acetyltransferases AAC (3)-Ia (aacC1), nucleotidyl transferases ANT (2'')-Ia (aadB), and ANT (3") -Ia (aadA1) genes among clinical isolates of A. baumannii and its relation to resis-tance to amikacin and gentamicin. Methods: The study included all clinical samples from intensive care units (ICUs) patients with suspected hospital acquired infections. Positive cultures were identified by Gram stain and complete biochemical identifications. An-tibiotic susceptibility was carried out by disc diffusion method. Minimum inhibitory concentration determination (MIC) to amikacin and gentamicin was performed by microdilution method. Polymerase chain reaction (PCR) was performed for detection of aadB, aadA1, aphA6, aadC1 genes. Results: The study included 1,200 bacterial isolates from patients admitted to ICUs during the period of the study. A. baumannii represented 100 isolates from Gram negative bacilli. The study of MIC of A. baumannii to amikacin and gentamicin revealed that 50 (50%) of the isolates had resistance by MIC study with 36 (72%) of those having high level aminoglycoside resistance (HLAR) and 14 (28%) had non-high-level aminoglycoside resistance. The most common prevalent resistant genes among A. baumannii resistance to aminoglycosides was aadB (42%), fol-lowed by aphA6 (26%). Less prevalent genes were aadA1 (18%) and aacC1 (12%). There were 24 isolates with negative PCR for the studied genes. In a comparison between the prevalence of resistant genes among A. baumannii with HLAR and non HLAR, there was a non-significant increase of aphA6 (30.6%) and aadB (44.4%) in HLAR isolates compared to non HLAR (14.3%, 35.7%, respectively; p = 0.2), with a significant increase in aacC1 28.6% in HLAR compared to 5.6% in non HLAR (p = 0.02). Conclusions: Half of the clinical isolates of A. baumannii have resistance to the aminoglycosides amikacin and gen-tamicin. Most isolates have a high resistance level to aminoglycosides. The isolates have different types of amino-glycoside modifying genes. Further studies are required to detect other genes associated with resistance to amino-glycosides.

WarA, a remote homolog of NpmA and KamB from Nocardia wallacei , confers broad spectrum aminoglycoside resistance in Nocardia and Mycobacteria

Identification on a New Subtype Gene of Aminoglycoside Modifying Enzyme in Multi-drug Resistant Acinetobacter baumannii

Evaluation of Aminoglycoside Resistance Phenotypes and Genotyping of Acetyltransferase in Escherichia Coli

Identification and characterization of a novel 6′-N-aminoglycoside acetyltransferase AAC(6′)-Va from a clinical isolate of Aeromonas hydrophila

The prevalence of 16S rRNA methylase genes in Acinetobacter baumannii

Biochemical and structural characterization of a class A β-lactamase from Nocardia cyriacigeorgica

RecA-Mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA

Widespread Occurrence of Aminoglycoside Resistance Due to ArmA Methylase in Imipenem-Resistant Acinetobacter Baumannii Isolates in China.

APH(3')-Ie, an aminoglycoside-modifying enzyme discovered in a rabbit-derived Citrobacter gillenii isolate

Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides

Exploring Nocardia's ecological spectrum and novel therapeutic frontiers through whole-genome sequencing: unraveling drug resistance and virulence factors

Human Intestinal Microbiome—A Reservoir of Aminoglycoside-N-Acetyltransferases—Drug Resistance Genes

Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase

AamA-mediated epigenetic control of genome-wide gene expression and phenotypic traits in Acinetobacter baumannii ATCC 17978

Identification and characterization of a novel β-lactamase gene, blaAMZ–1, from Achromobacter mucicolens

Aminoglycoside Resistance Genes in Acinetobacter baumannii Clinical Isolates

Widespread of 16S Rrna Methylases in Different Species of Aminoglycoside-Resistant Gram-negative Bacilli

Orthologous and Paralogous AmpD Peptidoglycan Amidases from Gram-Negative Bacteria

Coexistence of Arma and Genes Encoding Aminoglycoside-Modifying Enzymes in Acinetobacter Baumannii

Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria.

An aminoglycoside sensing riboswitch controls the expression of aminoglycoside resistance acetyltransferase and adenyltransferases.